The New Landscape of Drug Discovery in Europe
11 Sept 2013
Peter Simpsontalks about how drug discovery is changing, with particular emphasis on Europe. Collaborations between the big pharmaceutical companies and smaller biotech companies (Contract Research Organisations - CROs) is the driving force. Watch the video to learn how the ELRIG conference is enabling the drug discovery industry to change.
About the company
ELRIG
A not-for-profit organization whose purpose is to bring the life science and drug discovery community together to learn, share, connect, innovate and collaborate, on an open access basis.
Achieved through the provision of world class conferences, networking events, webinars and increasingly digital content.
Our community encompasses over 22,000 scientists from industry (pharma & biotech), academia & life-science suppliers (products & services).
All events are free-to-attend – supported by vendor sponsors and exhibitors.